Literature DB >> 21035566

Biased distribution of IS629 among strains in different lineages of enterohemorrhagic Escherichia coli serovar O157.

Eiji Yokoyama1, Ruiko Hashimoto, Yoshiki Etoh, Sachiko Ichihara, Kazumi Horikawa, Masako Uchimura.   

Abstract

The distribution of insertion sequence (IS) 629 among strains of enterohemorrhagic Escherichia coli serovar O157 (O157) was investigated and compared with the strain lineages defined by lineage specific polymorphism assay-6 (LSPA-6) to demonstrate the effectiveness of IS629 analysis for population genetics analysis. Using pulsed-field gel electrophoresis and variable-number tandem repeat typing, 140 strains producing both VT1 and VT2 and 98 strains producing only VT2 were selected from a total of 592 strains isolated from patients and asymptomatic carriers in Chiba Prefecture, Japan, during 2003-2008. By LSPA-6 analysis, six strains had atypical amplicon sizes in their Z5935 loci and five strains had atypical amplicon sizes in their arp-iclR intergenic regions. Sequence analyses of PCR amplified DNAs showed that five of the six loci used for LSPA-6 analysis had tandem repeats and the allele changes were due to changes in the number of tandem repeats. Subculturing and long-term incubation was found to have no detectable effect on the lineages defined by LSPA-6 analysis, demonstrating the robustness of LSPA-6 analysis. Minimum spanning tree analysis reconstruction revealed that strains in lineage I, I/II, and II clustered on separate branches, indicating that the distribution of IS629 was biased among O157 strains in different lineages. Strains with LSPA-6 codes 231111, 211113, and 211114 had atypical amplicon sizes and were clustered in lineage I/II branch, and strains with LSPA-6 codes 212114, 221123, 221223, 222123, 222224, 242123, 252123, and 242222 had atypical amplicon sizes and clustered in lineage II branches. Linkage disequilibrium was observed in strains in every lineage when the standardized index of association was calculated using IS629 distribution data. Therefore, the distribution analysis of IS629 may be effective for population genetics analysis of O157 due to the biased IS629 distribution among strains in the three O157 lineages.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21035566     DOI: 10.1016/j.meegid.2010.10.007

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  13 in total

1.  Variation in stress resistance patterns among stx genotypes and genetic lineages of shiga toxin-producing Escherichia coli O157.

Authors:  Ken-Ichi Lee; Nigel P French; Geoff Jones; Yukiko Hara-Kudo; Sunao Iyoda; Hideki Kobayashi; Yoshiko Sugita-Konishi; Hirokazu Tsubone; Susumu Kumagai
Journal:  Appl Environ Microbiol       Date:  2012-02-24       Impact factor: 4.792

2.  Geographically distinct Escherichia coli O157 isolates differ by lineage, Shiga toxin genotype, and total shiga toxin production.

Authors:  Glen E Mellor; Narelle Fegan; Kari S Gobius; Helen V Smith; Amy V Jennison; Beatriz A D'Astek; Marta Rivas; Smriti Shringi; Katherine N K Baker; Thomas E Besser
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

3.  Multivariate analyses revealed distinctive features differentiating human and cattle isolates of Shiga toxin-producing Escherichia coli O157 in Japan.

Authors:  Ken-ichi Lee; Nigel P French; Yukiko Hara-Kudo; Sunao Iyoda; Hideki Kobayashi; Yoshiko Sugita-Konishi; Hirokazu Tsubone; Susumu Kumagai
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

4.  Phylogeny, Prevalence, and Shiga Toxin (Stx) Production of Clinical Escherichia coli O157 Clade 2 Strains Isolated in Shimane Prefecture, Japan.

Authors:  Jun Kawase; Shinichiro Hirai; Eiji Yokoyama; Fumi Hayashi; Morito Kurosaki; Yuta Kawakami; Aiko Fukuma; Tomotake Sakai; Mayuko Kotani; Hiroshi Asakura
Journal:  Curr Microbiol       Date:  2020-10-23       Impact factor: 2.188

5.  Different IS629 transposition frequencies exhibited by Escherichia coli O157:H7 strains in the stepwise evolutionary model.

Authors:  Lydia V Rump; Markus Fischer; Narjol González-Escalona
Journal:  Appl Environ Microbiol       Date:  2011-05-27       Impact factor: 4.792

6.  Phylogenetically related Argentinean and Australian Escherichia coli O157 isolates are distinguished by virulence clades and alternative Shiga toxin 1 and 2 prophages.

Authors:  Glen E Mellor; Eby M Sim; Robert S Barlow; Beatriz A D'Astek; Lucia Galli; Isabel Chinen; Marta Rivas; Kari S Gobius
Journal:  Appl Environ Microbiol       Date:  2012-04-27       Impact factor: 4.792

7.  Multilocus genotype analysis of Escherichia coli O157 isolates from Australia and the United States provides evidence of geographic divergence.

Authors:  Glen E Mellor; Thomas E Besser; Margaret A Davis; Brittany Beavis; Wookyung Jung; Helen V Smith; Amy V Jennison; Christine J Doyle; P Scott Chandry; Kari S Gobius; Narelle Fegan
Journal:  Appl Environ Microbiol       Date:  2013-06-14       Impact factor: 4.792

8.  Prevalence, distribution and evolutionary significance of the IS629 insertion element in the stepwise emergence of Escherichia coli O157:H7.

Authors:  Lydia V Rump; Markus Fischer; Narjol Gonzalez-Escalona
Journal:  BMC Microbiol       Date:  2011-06-14       Impact factor: 3.605

9.  Comparative genomics of enterohemorrhagic Escherichia coli O145:H28 demonstrates a common evolutionary lineage with Escherichia coli O157:H7.

Authors:  Kerry K Cooper; Robert E Mandrell; Jacqueline W Louie; Jonas Korlach; Tyson A Clark; Craig T Parker; Steven Huynh; Patrick S Chain; Sanaa Ahmed; Michelle Qiu Carter
Journal:  BMC Genomics       Date:  2014-01-10       Impact factor: 3.969

10.  Escherichia coli O157:H7 strains harbor at least three distinct sequence types of Shiga toxin 2a-converting phages.

Authors:  Shuang Yin; Brigida Rusconi; Fatemeh Sanjar; Kakolie Goswami; Lingzi Xiaoli; Mark Eppinger; Edward G Dudley
Journal:  BMC Genomics       Date:  2015-09-29       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.